Brief: Lixte Biotechnology Announces Pricing Of $3.5 Mln Registered Direct Offering And Concurrent Private Placement
July 18 (Reuters) - Lixte Biotechnology Holdings Inc
LIXT.O :
* LIXTE BIOTECHNOLOGY ANNOUNCES PRICING OF $3.5 MILLION
REGISTERED
DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT PRICED
AT-THE-MARKET UNDER NASDAQ RULES
* LIXTE BIOTECHNOLOGY HOLDINGS INC - OFFERING AT A PURCHASE
PRICE
OF $6.00 PER COMMON SHARE
Source text for Eikon: ID:nGNXRnlPq
Further company coverage: LIXT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NOMAD Power Solutions
See all newsBrief: Nomad Power Solutions Files 2026 Second Quarter Form 10-Q, Provides Business Update
U.S. STOCKS ON THE MOVE-SpaceX, Tesla, Woodside Energy Group
U.S. STOCKS ON THE MOVE-SpaceX, SharonAI, Medline
U.S. STOCKS ON THE MOVE-SpaceX, SharonAI, Medline
LIXTE to buy battery firm NOMAD, shifts away from cancer drugs; shares rise